Therapeutic Asset Ratings
7,021 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Girentuximab
Kidney Cancer
Memorial Sloan Kettering Cancer Center
P3
BB
(70)
Glecirasib
Non-Small Cell Lung Carcinoma
Shandong Suncadia Medicine Co., Ltd.
P3
BB
(70)
hs-20093
Small Cell Lung Carcinoma
Shanghai Hansoh Biomedical Co., Ltd
P3
BB
(70)
HUMAN PAPILLOMAVIRUS SEROTYPE 58 WHOLE
Human Papilloma Virus Infection
Beijing Health Guard Biotechnology, Inc
P3
BB
(70)
Hydroxypropyl-Beta-Cyclodextrin
Niemann-Pick Disease, Type C1
Cyclo Therapeutics, Inc.
P3
BB
(70)
Idarubicine
Childhood Acute Myeloid Leukemia
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
P3
BB
(70)
Idarubicine
Leukemia
Affiliated Hospital of Nantong University
P3
BB
(70)
Idarubicine
Myelodysplastic Syndrome With Excess Blasts
Fred Hutchinson Cancer Center
P3
BB
(70)
Ifosfamide
Lymphoma
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
P3
BB
(70)
Immunoglobulin G1, anti-(human epidermal growth factor receptor) (human-Mus musculus monoclonal JMT101 ?1-chain), disulfide with human-Mus musculus monoclonal JMT101 ?-chain, dimer
Non-Small Cell Lung Carcinoma
Shanghai JMT-Bio Inc.
P3
BB
(70)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Stage IV Breast Cancer
SWOG Cancer Research Network
P3
BB
(70)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Aggressive B-Cell Non-Hodgkin Lymphoma
Shanghai EpimAb Biotherapeutics Co., Ltd.
P3
BB
(70)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
High Grade B-Cell Lymphoma
National Cancer Institute (NCI)
P3
BB
(70)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Secondary Progressive Multiple Sclerosis
Cairo University
P3
BB
(70)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Waldenstrom Macroglobulinemia
Memorial Sloan Kettering Cancer Center
P3
BB
(70)
Inno-206
Carcinoma Of Urethra
University of Southern California
P3
BB
(70)
Inno-206
Fallopian Tube Neoplasm
Eli Lilly and Company
P3
BB
(70)
Inno-206
High Grade B-Cell Lymphoma
National Cancer Institute (NCI)
P3
BB
(70)
Inno-206
Inflammatory Breast Carcinoma
M.D. Anderson Cancer Center
P3
BB
(70)
Inno-206
Ovarian Serous Adenocarcinoma
National Cancer Institute (NCI)
P3
BB
(70)
Inno-206
Childhood Acute Lymphoblastic Leukemia
Tanja Andrea Gruber
P3
BB
(70)
Iparomlimab
ES-SCLC
Sun Yat-sen University
P3
BB
(70)
Irinotecan
Adult Glioblastoma
NaviFUS Corporation
P3
BB
(70)
Irinotecan
Fallopian Tube Clear Cell Adenocarcinoma
National Cancer Institute (NCI)
P3
BB
(70)
Irinotecan
Fallopian Tube Endometrioid Adenocarcinoma
National Cancer Institute (NCI)
P3
BB
(70)
Showing 501 to 525 of 7,021 assets
Previous
Page 21 of 281
Next